The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 trial of ixazomib, cyclophosphamide, and dexamethasone for newly diagnosed multiple myeloma (NDMM).
 
Martha Lacy
Research Funding - Celgene (Inst)
 
P. Leif Bergsagel
No Relationships to Disclose
 
Betsy LaPlant
No Relationships to Disclose
 
Alese Halvorson
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
Nelson Leung
No Relationships to Disclose
 
Ronald S. Go
No Relationships to Disclose
 
David Dingli
No Relationships to Disclose
 
Prashant Kapoor
Research Funding - Celgene (Inst); Takeda (Inst)
 
Morie A. Gertz
Honoraria - Celgene; Isis Pharmaceuticals; Med Learning Group; Millennium; Novartis; Onyx; Prothena; Research to Practice; Sanofi
Consulting or Advisory Role - Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Yi Lin
No Relationships to Disclose
 
Angela Dispenzieri
Consulting or Advisory Role - GlaxoSmithKline (Inst); Prothena (Inst)
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Yi Lisa Hwa
No Relationships to Disclose
 
Amie Fonder
No Relationships to Disclose
 
Rafael Fonseca
No Relationships to Disclose
 
Suzanne R. Hayman
No Relationships to Disclose
 
A. Keith Stewart
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Novartis
 
Joseph Mikhael
Research Funding - Abbvie (Inst); Celgene (Inst); Onyx (Inst); Sanofi (Inst)
 
S. Vincent Rajkumar
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celgene (Inst); GlycoMimetics (Inst); Janssen (Inst); Kedrion Biopharma; Noxxon Pharma; Sanofi (Inst); Skyline Diagnostics; Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)